Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 7.0 | 5.0 | 0.0 | 15.8 |
| Revenue growth | | -100.0% | 40.0% | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 19.1 |
| Gross profit | 0.0 | 0.0 | 7.0 | 5.0 | 0.0 | -3.3 |
| Gross margin | | | 100.0% | 100.0% | | -21.1% |
| Research and development | 37.1 | 41.0 | 40.2 | 33.0 | 25.7 | |
| General and administrative | 15.2 | 13.2 | 13.8 | 10.2 | 5.6 | 3.3 |
| EBIT | -52.3 | -54.2 | -46.9 | -38.2 | -31.3 | -19.1 |
| EBIT margin | | | -670.5% | -764.1% | | -121.1% |
| Pre-tax income | -47.1 | -50.5 | -43.2 | -32.5 | -29.9 | -19.1 |
| Income taxes | 0.0 | 0.0 | 0.7 | 0.5 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | | | 0.0% | 0.0% |
| Net income | -47.1 | -50.5 | -43.9 | -42.1 | -29.9 | -19.1 |
| Net margin | | | -626.4% | -841.9% | | -121.0% |
| |
| Diluted EPS | ($1.09) | ($2.10) | ($3.33) | ($12.31) | ($13,795.76) | |
| Shares outstanding (diluted) | 43.3 | 24.1 | 13.2 | 3.4 | 0.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|